MetLife, Inc. (MET) is a Insurance - Life company in the Financial Services sector, currently trading at $76.04. It has a SharesGrow Score of 65/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of MET = $116.55 (+53.3% from the current price, the stock appears undervalued). Analyst consensus target is MET = $97 (+27.3% upside).
Valuation: MET trades at a trailing Price-to-Earnings (P/E) of 14.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.23.
Financials: revenue is $77.1B, +4.5%/yr average growth. Net income is $3.4B, growing at +28.9%/yr. Net profit margin is 4.4% (thin). Gross margin is 36.4% (-63.6 pp trend).
Balance sheet: total debt is $20.2B against $28.4B equity (Debt-to-Equity (D/E) ratio 0.71, moderate). Current ratio is 0.65 (tight liquidity). Debt-to-assets is 2.7%. Total assets: $745.2B.
Analyst outlook: 24 / 32 analysts rate MET as buy (75%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 80/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 33/100 (Fail), Moat 59/100 (Partial), Future 79/100 (Pass), Income 30/100 (Fail).
